Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
ON-01910
Cat No.
CEI-0303
Description
ON 01910 can inhibit polo-like kinase 1 (Plk1) with IC50 of 9 nM.
CAS No.
1225497-78-8
Molecular Weight
473.47
Purity
>99%
Storage
2 years at -20 centigrade
Targets
PLK1
Molecular Formula
C21H24NNaO8S
Solubility
DSMO Water Ethanol
In vitro
ON 01910 is a novel polo-like kinase 1 (Plk1) inhibitor and it inhibit PLK1 with IC50 of 9 nM. ON 01910 also shows cytotoxic activity against a variety of human tumor cell lines in vitro. ON 01910 can induce three major abnormalities in tumor cells, including abnormal cell division (irregular chromosomal segregation and cytokinesis), G2-M arrest and apoptosis, and decreased expression of Cdc25C in many tumor cell lines.
In vivo
In rats, single doses of 300 and 600 mg/m 2 of ON01910 produced no toxicity, and 1200 mg/m2 had only slight toxicity. There was no evidence of significant myelotoxicity, neuropathy, or cardiotoxicity in these toxicology studies. In xenograft mouse model systems, ON01910 inhibited the growth of a wide variety of human tumors, including liver, breast, and pancreatic cancers.
Download
Download Datasheet